Korean J Gastroenterol.  2015 May;65(5):326-329. 10.4166/kjg.2015.65.5.326.

Rapidly Growing Interval Colon Cancer

• Kim JH
• Park MI

• KMID: 2373231
• DOI: http://doi.org/10.4166/kjg.2015.65.5.326

Abstract

No abstract available.

MeSH Terms

Angiogenesis Inhibitors/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Bevacizumab/administration & dosage
Camptothecin/analogs & derivatives/therapeutic use
Colonic Neoplasms/*diagnosis/drug therapy/pathology
Colonoscopy
Female
Fluorouracil/therapeutic use
Humans
Leucovorin/therapeutic use
Liver Neoplasms/drug therapy/pathology/secondary
Lung Neoplasms/drug therapy/pathology/secondary
Middle Aged
Positron-Emission Tomography
Tomography, X-Ray Computed
Angiogenesis Inhibitors
Bevacizumab
Camptothecin
Fluorouracil
Leucovorin

Figure

• 

  Fig. 1. Initial abdomen-pelvis CT and endoscopic findings. (A, B) No ab-normal findings are noted on abdo-men-pelvis CT (A, transverse view; B, coronal view). (C) About 10 mm sized, pedunculated polyp is observed on sigmoid colon and removed by endoscopic mucosal resection. (D) No ab-normal endoscopic findings are present on cecum.

• 

  Fig. 2. Follow-up abdomen-pelvis CT findings. Irregular wall thickening and luminal narrowing of the cecum and ascending colon is seen along with multiple liver metastasis.

• 

  Fig. 3. Follow-up endoscopic findings. (A) About 5 cm sized, Borrmann type 3 tumor is observed on ascending colon. (B) Because of the luminal narrowing, the scope could not be passed into the cecum.

Reference

References

1. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 2012; 118:3044–3052.

2. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011; 140:65–72.

3. Kim CJ, Jung YS, Park JH, et al. Prevalence, clinicopathologic characteristics, and predictors of interval colorectal cancers in Korean population. Intest Res. 2013; 11:178–183.

4. Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Colonoscopic miss rates for right-sided colon cancer: a pop-ulation-based analysis. Gastroenterology. 2004; 127:452–456.

5. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007; 132:96–102.

6. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006; 101:343–350.

7. Heresbach D, Barrioz T, Lapalus MG, et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to- back video colonoscopies. Endoscopy. 2008; 40:284–290.

8. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004; 141:352–359.

9. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011; 9:42–46.

10. Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp re-section during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013; 144:74–80.e1.

11. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite in-stability in interval colon cancers. Gastroenterology. 2006; 131:1700–1705.

12. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010; 105:1189–1195.

13. Hong SN, Yang DH, Kim YH, et al. Multi-Society Task Force for-Development of Guidelines for Colorectal Polyp Screening, Surveillance and Management. Korean guidelines for post-polypectomy colonoscopic surveillance. Korean J Gastroenterol. 2012; 59:99–117.